Abstract
Objective: Yes-associated protein (YAP) is a key effector of the hippo tumor suppressive pathway, and its abnormal expression is associated with carcinogenesis and chemoresistance in a number of malignancies. There were no relevant data in ovarian cancer. We examined the biological roles of YAP and the therapeutic effect of YAP silencing using siRNA, dobutamine, single or combined.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
